Marina Jelovac is a Research Assistant at the Institute of Molecular Genetics and Genetic Engineering, University of Belgrade. Her research focuses on pharmacogenomics of rare diseases and autoimmune disorders, specifically sistemic sclerosis. Currently she is working on the application of novel bioinformatic tools for analysis of NGS-generated data and on the development of models for estimation of risk of disease progression, therapy inefficiency or adverse drug reactions based on variants present across the genome. Marina Jelovac will contribute to WP1, WP2, WP3,WP4 and WP6.